These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 17215344
1. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344 [Abstract] [Full Text] [Related]
7. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Cejudo MA, Gallego AG, Lacasa EC, Aller AI, Romero A, García JP, Andrés GQ, Martín-Mazuelos E. Med Mycol; 2010 Aug; 48(5):710-9. PubMed ID: 20109092 [Abstract] [Full Text] [Related]
10. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Fothergill A, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE. J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103 [Abstract] [Full Text] [Related]
12. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA. J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878 [Abstract] [Full Text] [Related]
13. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. Tan GL, Peterson EM. J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992 [Abstract] [Full Text] [Related]
14. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501 [Abstract] [Full Text] [Related]
15. [Evaluation of the VITEK 2 system (AST-YSO1 cards) for antifungal susceptibility testing against different Candida species]. Ochiuzzi ME, Arechavala A, Guelfand L, Maldonado I, Soloaga R, Red de Micología CABA, Argentina. Rev Argent Microbiol; 2014 Jan; 46(2):111-8. PubMed ID: 25011594 [Abstract] [Full Text] [Related]
16. Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole. Pfaller MA, Diekema DJ, Procop GW, Wiederhold NP. J Clin Microbiol; 2014 Jun; 52(6):2126-30. PubMed ID: 24719450 [Abstract] [Full Text] [Related]
17. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. Lee SC, Lo HJ, Fung CP, Lee N, See LC. J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647 [Abstract] [Full Text] [Related]
18. [Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates]. Rodero L, Córdoba S, Vivot W, Campo M, Corfield P, Olguín C, Cuirolo A, Soria M, Guelfand L, Canteros CE, Davel G, RED WHONET. Rev Argent Microbiol; 2006 Apr; 38(3):155-63. PubMed ID: 17152217 [Abstract] [Full Text] [Related]